Olfr498 Inhibitors
Olfr498, a member of the olfactory receptor protein family, serves as a crucial player in the initiation of the neuronal response responsible for the perception of smell. Functioning within the intricate landscape of the olfactory system, Olfr498 is a G-protein-coupled receptor (GPCR) that interacts with odorant molecules in the nose. This interaction sets off a cascade of events, ultimately triggering a neuronal response that contributes to the conscious experience of various odors. Structurally, Olfr498 shares a 7-transmembrane domain architecture with neurotransmitter and hormone receptors, a characteristic feature of the GPCR family. The coding-exon genes that give rise to olfactory receptors, including Olfr498, contribute to the extensive diversity within this gene family, constituting the largest in the genome. Importantly, the nomenclature assigned to olfactory receptor genes and proteins for this organism is independent of other organisms, underscoring the uniqueness and complexity of olfactory signaling.
In the realm of Olfr498 inhibition, a diverse array of chemical agents can modulate its function, either directly or indirectly. Direct inhibitors exert their influence by specifically targeting components of signaling pathways associated with Olfr498. For instance, MEK inhibitors like PD98059 directly impede the MAPK pathway, disrupting downstream elements involved in olfactory signal transduction. Similarly, p38 MAPK inhibitors such as SB203580 specifically target the MAPK pathway, affecting Olfr498 and altering the perception of odors in the olfactory system. On the other hand, indirect inhibitors operate by influencing cellular processes related to Olfr498 function. Calcium channel blockers like Verapamil, for instance, may impact Olfr498 by modulating intracellular calcium levels, thereby altering G-protein-mediated transduction and the neuronal response to odorant signals. These diverse mechanisms of inhibition underscore the complexity of olfactory signal transduction, providing valuable insights into the regulatory networks governing Olfr498 and contributing to the broader understanding of olfactory receptor function within the intricate molecular landscape of smell perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein, a Gβγ inhibitor, directly inhibits Olfr498 by disrupting G-protein signaling. Its interference with G-protein-mediated transduction could impact the neuronal response involved in olfactory signal transduction, affecting the perception of smell. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, directly inhibits the MAPK pathway. By disrupting this pathway, it may influence downstream elements affecting Olfr498, potentially altering G-protein-coupled receptor signaling and impacting olfactory perception. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
PTX (Pertussis toxin) inhibits G-protein signaling. Olfr498, being a GPCR, may be indirectly affected, as pertussis toxin disrupts G-protein-mediated transduction. This interference could alter the neuronal response to odorant signals in the olfactory system. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may indirectly influence Olfr498 by inhibiting the PI3K-Akt pathway. Modulating this pathway could impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, a calcium channel blocker, could indirectly impact Olfr498 by modulating intracellular calcium levels. Changes in calcium signaling may affect G-protein-mediated transduction and alter the neuronal response to odorant molecules, impacting olfactory perception. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, directly targets the MAPK pathway. Inhibition of this pathway may affect downstream elements involved in olfactory signal transduction, potentially influencing Olfr498 and altering the perception of odors in the olfactory system. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, could indirectly influence Olfr498 by disrupting the PI3K-Akt pathway. Modulating this pathway may impact cellular processes associated with olfactory signal transduction, potentially affecting the perception of odors. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, a SERCA inhibitor, may indirectly inhibit Olfr498 by disrupting calcium homeostasis. Changes in intracellular calcium levels could influence G-protein-mediated transduction, altering the neuronal response to odorant signals and impacting olfactory perception. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, a CaMKII inhibitor, may indirectly affect Olfr498 by modulating calcium/calmodulin-dependent signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X, a PKC inhibitor, may indirectly influence Olfr498 by modulating PKC-mediated signaling pathways. Disruption of these pathways could impact G-protein-coupled receptor function, potentially altering the neuronal response to odorant signals in the olfactory system. | ||||||